Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

NCT05786339 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Therapeutic Equivalency

Interventions

DRUG: Tested Irbesartan Tablet
DRUG: Reference Irbesartan Tablet

Sponsor

The Affiliated Hospital of Qingdao University